Glial fibrillary acidic protein: a potential biomarker for small fiber neuropathy?
Serum GFAP levels are reduced in persons with DPN compared to persons without DPN and controls. Reduced serum GFAP levels may be associated with reduced markers of small nerve fiber damage obtained from quantitative sensory testing in people with diabetes.
Authors
- Claus Vinter Bødker Hviid (ORCID: https://orcid.org/0000-0003-1740-7555)
- Johan Røikjer (ORCID: https://orcid.org/0000-0002-4578-1328)
- Nicklas H. Rasmussen
Institutions
- Steno Diabetes Centers (DK)
- Aalborg University Hospital (DK)
- Aalborg University (DK)
Publication Details
- Journal
- Acta Diabetologica
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1007/s00592-025-02500-8
- Citations
- 2
- Primary Topic
- Pain Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.33
Funders
- Aalborg Universitet
- Aalborg Universitetshospital